Conmed vs Penumbra
Conmed and Penumbra are similar in size: $1.37bn and $1.40bn of revenue in their latest fiscal years. Penumbra grew faster (17.5% against 5.2%). Penumbra kept more of each dollar of sales as profit: a net margin of 12.7% against 3.4%. Penumbra carries less debt relative to equity (0.0% against 80.8%).
| Latest fiscal year | ConmedCNMD, 2025 | PenumbraPEN, 2025 |
|---|---|---|
| Revenue | $1.37bn | $1.40bn |
| Revenue growth | 5.2% | 17.5% |
| Net income | $47.1m | $178m |
| Operating margin | 7.5% | 13.5% |
| Net margin | 3.4% | 12.7% |
| Return on equity | 4.7% | 13.8% |
| Free cash flow | $151m | $175m |
| Cash | $40.8m | $187m |
| Total debt | $835m | $0 |
| Debt to equity | 80.8% | 0.0% |
| Dividend per share | $0.60 | — |
| Dividend yield | 1.7% | — |
| Share buybacks | — | $0 |
| Employees | 3,900 | 4,700 |
| Market value | $1.46bn | $12.69bn |
| Price vs our value range | Below our value range | Above our value range |
| Moat score | 63 (Moderate) | 44 (Weak) |
| Insider trades, 12 months | 0 buys, 2 sales | 0 buys, 32 sales |